Altimmune (ALT) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Altimmune (ALT) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Altimmune

· ALT

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

577.718 M

-3.70%

General

Market Cap: $577.72M
Enterprise Value: $528.89M
Shares Outstanding: 194,470,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: -48306.45%
Operating Margin: -323306.45%
Net Profit Margin: -296000.00%
FCF Margin: -246974.19%
ROA: -17.40%
ROE: -31.41%
ROIC: -19.47%
Current Ratio: 26.78
Debt-to-Equity: 0.08
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: 17941.79
P/FCF: —
P/B: 1.17
EV/EBITDA: -5.71

Growth

Rev 1Y: 105.00%
Rev 1Y Fwd Est: -95.43%
Rev 3Y (CAGR): —
Rev 5Y (CAGR): -65.33%
Rev 10Y (CAGR): -42.64%
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —

Income Statement (TTM)

Revenue: $31K
Gross Margin: -48306.45%
Operating Expenses: $85.27M
Operating Income: -$100.23M
Net Profit: -$91.76M

Balance Sheet

EPS 5Y (CAGR)

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $63.05M
Working Capital: $322.31M
Total Assets: $527.21M
Net Debt: -$27.3M
Total Liabilities: $53M
Total Equity: $474.21M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$76.51M
Cash Flow from Investing: -$453.61M
Cash Flow from Financing: $410.02M
Free Cash Flow: -$76.56M
Capital Expenditures: $54K